Henderson Es

864 total citations
29 papers, 693 citations indexed

About

Henderson Es is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Henderson Es has authored 29 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Henderson Es's work include Chronic Lymphocytic Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (7 papers) and Acute Myeloid Leukemia Research (5 papers). Henderson Es is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (7 papers) and Acute Myeloid Leukemia Research (5 papers). Henderson Es collaborates with scholars based in United States. Henderson Es's co-authors include Sigurður Björnsson, HD Preisler, Creaven Pj, Arnold I. Freeman, Youcef M. Rustum, Holland Jf, A Goldin, Emil Frei, Howard Ozer and Tao Han and has published in prestigious journals such as Blood and PubMed.

In The Last Decade

Henderson Es

28 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henderson Es United States 15 293 227 195 157 155 29 693
M Weil France 16 374 1.3× 446 2.0× 377 1.9× 285 1.8× 204 1.3× 69 1.1k
Pearl Leavitt United States 10 561 1.9× 255 1.1× 534 2.7× 268 1.7× 137 0.9× 13 1.1k
C Jacquillat France 10 149 0.5× 168 0.7× 102 0.5× 120 0.8× 76 0.5× 62 444
Juliet Hananian United States 9 120 0.4× 168 0.7× 245 1.3× 142 0.9× 113 0.7× 15 645
RM Stone United States 9 570 1.9× 215 0.9× 469 2.4× 282 1.8× 123 0.8× 13 940
Marise Weil France 6 234 0.8× 194 0.9× 88 0.5× 250 1.6× 48 0.3× 10 591
Claudia Corrado Argentina 14 206 0.7× 265 1.2× 57 0.3× 207 1.3× 115 0.7× 28 661
Isamu Sugiura Japan 17 905 3.1× 187 0.8× 506 2.6× 172 1.1× 293 1.9× 80 1.2k
R. D. Brunning United States 12 252 0.9× 84 0.4× 65 0.3× 103 0.7× 194 1.3× 16 625
F. R. Appelbaum United States 14 552 1.9× 287 1.3× 245 1.3× 154 1.0× 178 1.1× 25 1.1k

Countries citing papers authored by Henderson Es

Since Specialization
Citations

This map shows the geographic impact of Henderson Es's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henderson Es with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henderson Es more than expected).

Fields of papers citing papers by Henderson Es

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henderson Es. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henderson Es. The network helps show where Henderson Es may publish in the future.

Co-authorship network of co-authors of Henderson Es

This figure shows the co-authorship network connecting the top 25 collaborators of Henderson Es. A scholar is included among the top collaborators of Henderson Es based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henderson Es. Henderson Es is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Da, Van Echo, et al.. (1986). Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study.. PubMed. 70(9). 1125–6. 16 indexed citations
2.
3.
4.
Es, Henderson, et al.. (1983). Possible specific chromosome change in prolymphocytic leukemia. Blood. 62(4). 729–736. 2 indexed citations
5.
Pearce, John A., et al.. (1983). Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin's disease.. PubMed. 67(12). 1099–103. 56 indexed citations
6.
Es, Henderson, et al.. (1983). Possible specific chromosome change in prolymphocytic leukemia. Blood. 62(4). 729–736. 32 indexed citations
7.
Pj, Creaven, et al.. (1982). Dialogue en enfer. PubMed. 66(1). 81–4. 4 indexed citations
8.
Ra, Kyle, et al.. (1982). Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.. PubMed. 66(3). 451–6. 22 indexed citations
9.
Es, Henderson, et al.. (1981). Defective immunoregulatory T-cell function in chronic lymphocytic leukemia. Blood. 58(6). 1182–1189. 3 indexed citations
10.
Cp, Karakousis, Sigurður Björnsson, Henderson Es, et al.. (1980). cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma.. PubMed. 63(11-12). 2009–10. 16 indexed citations
11.
Preisler, HD, Youcef M. Rustum, Henderson Es, et al.. (1979). Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood. 53(3). 455–464. 88 indexed citations
12.
Preisler, HD, Youcef M. Rustum, Henderson Es, et al.. (1979). Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood. 53(3). 455–464. 120 indexed citations
13.
Gailani, Salman, et al.. (1977). Plasma cell leukemia: response to conventional myeloma therapy.. PubMed. 8(6). 403–14. 4 indexed citations
14.
Björnsson, Sigurður, et al.. (1977). Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.. PubMed. 61(1). 89–92. 26 indexed citations
15.
Es, Henderson, et al.. (1975). Granulocyte transfusions for infection during neutropenia.. PubMed. 2(4). 361–8. 6 indexed citations
16.
Es, Henderson, et al.. (1973). Immunotherapy in previously treated acute lymphatic leukemia.. PubMed. 39. 177–87. 19 indexed citations
17.
Lippman, M. E., Richard A. Zager, & Henderson Es. (1972). High dose daunorubicin (NSC-83142) in the treatment of advanced acute myelogenous leukemia.. PubMed. 56(6). 755–60. 9 indexed citations
18.
Goldin, A, et al.. (1971). The chemotherapy of human and animal acute leukemia.. PubMed. 55(4). 309–505. 51 indexed citations
19.
Es, Henderson. (1970). Combinations, schedules, and new agents for the chemotherapy of acute leukemia.. PubMed. 6. 119–26.
20.
Es, Henderson. (1967). Combination chemotherapy of acute lymphocytic leukemia of childhood.. PubMed. 27(12). 2570–2. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Weil Breakdown of academic impact, for papers by Pearl Leavitt Breakdown of academic impact, for papers by C Jacquillat Breakdown of academic impact, for papers by Juliet Hananian Breakdown of academic impact, for papers by RM Stone Breakdown of academic impact, for papers by Marise Weil Breakdown of academic impact, for papers by Claudia Corrado Breakdown of academic impact, for papers by Isamu Sugiura Breakdown of academic impact, for papers by R. D. Brunning Breakdown of academic impact, for papers by F. R. Appelbaum
Rankless by CCL
2026